E
Silexion Therapeutics Corp SLXN
$3.78 $0.051.34% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024
Revenue --
Total Other Revenue --
Total Revenue --
Cost of Revenue --
Gross Profit --
SG&A Expenses 359.04%
Depreciation & Amortization --
Other Operating Expenses --
Total Operating Expenses 389.22%
Operating Income -389.22%
Income Before Tax -363.72%
Income Tax Expenses 1,050.00%
Earnings from Continuing Operations -363.84%
Earnings from Discontinued Operations --
Extraordinary Item & Accounting Change --
Minority Interest in Earnings 1,788.89%
Net Income -362.75%
EBIT -389.22%
EBITDA -388.36%
EPS Basic -204.96%
Normalized Basic EPS -204.65%
EPS Diluted -204.96%
Normalized Diluted EPS -204.65%
Average Basic Shares Outstanding 150.34%
Average Diluted Shares Outstanding 150.34%
Dividend Per Share --
Payout Ratio --